Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Braithwaite

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Neuroscience and Biobehavioral Reviews|November 30, 2019
Aging: therapeutics for a healthy futureRobert Hodgson, Brian K Kennedy, Eliezer Masliah, et al.
The European Journal of Neuroscience|July 6, 2006
Regulation of NMDA receptor trafficking and function by striatal-enriched tyrosine phosphatase (STEP)Steven P Braithwaite, Michael Adkisson, John Leung, et al.
The European Journal of Neuroscience|May 1, 2008
Expression and function of striatal enriched protein tyrosine phosphatase is profoundly altered in cerebral ischemiaSteven P Braithwaite, Jian Xu, John Leung, et al.
Plos One|July 23, 2013
A pharmacological screening approach for discovery of neuroprotective compounds in ischemic strokeSimret Beraki, Lily Litrus, Liza Soriano, et al.
Annals of Neurology|March 31, 2015
Dual κ-agonist/μ-antagonist opioid receptor modulation reduces levodopa-induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of Parkinson diseaseLisa F Potts, Eun S Park, Jong-Min Woo, et al.
Journal of Neuropathology and Experimental Neurology|December 28, 2017
Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer DiseaseHye-Jin Park, Kang-Woo Lee, Stephanie Oh, et al.
Plos One|November 10, 2010
Identification and characterization of a leucine-rich repeat kinase 2 (LRRK2) consensus phosphorylation motifPooja P Pungaliya, Yuchen Bai, Kerri Lipinski, et al.
Neurobiology of Disease|May 11, 2010
Inhibition of c-Jun kinase provides neuroprotection in a model of Alzheimer's diseaseSteven P Braithwaite, Ralf S Schmid, Dong Ning He, et al.
Annals of Clinical and Translational Neurology|October 19, 2016
Dysregulation of protein phosphatase 2A in parkinson disease and dementia with lewy bodiesHye-Jin Park, Kang-Woo Lee, Eun S Park, et al.
The FEBS Journal|December 17, 2008
Investigation of leucine-rich repeat kinase 2 : enzymological properties and novel assaysVasanti S Anand, Laurie J Reichling, Kerri Lipinski, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Neuroscience and Biobehavioral Reviews|November 30, 2019
Aging: therapeutics for a healthy futureRobert Hodgson, Brian K Kennedy, Eliezer Masliah, et al.
The European Journal of Neuroscience|July 6, 2006
Regulation of NMDA receptor trafficking and function by striatal-enriched tyrosine phosphatase (STEP)Steven P Braithwaite, Michael Adkisson, John Leung, et al.
The European Journal of Neuroscience|May 1, 2008
Expression and function of striatal enriched protein tyrosine phosphatase is profoundly altered in cerebral ischemiaSteven P Braithwaite, Jian Xu, John Leung, et al.
Plos One|July 23, 2013
A pharmacological screening approach for discovery of neuroprotective compounds in ischemic strokeSimret Beraki, Lily Litrus, Liza Soriano, et al.
Annals of Neurology|March 31, 2015
Dual κ-agonist/μ-antagonist opioid receptor modulation reduces levodopa-induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of Parkinson diseaseLisa F Potts, Eun S Park, Jong-Min Woo, et al.
Journal of Neuropathology and Experimental Neurology|December 28, 2017
Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer DiseaseHye-Jin Park, Kang-Woo Lee, Stephanie Oh, et al.
Plos One|November 10, 2010
Identification and characterization of a leucine-rich repeat kinase 2 (LRRK2) consensus phosphorylation motifPooja P Pungaliya, Yuchen Bai, Kerri Lipinski, et al.
Neurobiology of Disease|May 11, 2010
Inhibition of c-Jun kinase provides neuroprotection in a model of Alzheimer's diseaseSteven P Braithwaite, Ralf S Schmid, Dong Ning He, et al.
Annals of Clinical and Translational Neurology|October 19, 2016
Dysregulation of protein phosphatase 2A in parkinson disease and dementia with lewy bodiesHye-Jin Park, Kang-Woo Lee, Eun S Park, et al.
The FEBS Journal|December 17, 2008
Investigation of leucine-rich repeat kinase 2 : enzymological properties and novel assaysVasanti S Anand, Laurie J Reichling, Kerri Lipinski, et al.
Pageof 3